Search

Author/Creator Yang, Cheng Y.

1. Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®. Issue 16 (15th August 2019)

Authors:
Taylor, James G.; Zipfel, Sheila; Ramey, Kyla; Vivian, Randy; Schrier, Adam; Karki, Kapil K.; Katana, Ashley; Kato, Darryl; Kobayashi, Tetsuya; Martinez, Ruben; Sangi, Michael; Siegel, Dustin; Tran, Chinh V.; Yang, Zheng-Yu; Zablocki, Jeff; Yang, Cheng Y.; Wang, Yujin; Wang, Kelly; Chan, Katie; B...
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 29:Issue 16(2019)
Page Start:
2428
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi® and Epclusa®. Issue 16 (15th August 2019)

Authors:
Link, John O.; Taylor, James G.; Trejo-Martin, Alejandra; Kato, Darryl; Katana, Ashley A.; Krygowski, Evan S.; Yang, Zheng-Yu; Zipfel, Sheila; Cottell, Jeromy J.; Bacon, Elizabeth M.; Tran, Chinh V.; Yang, Cheng Y.; Wang, Yujin; Wang, Kelly W.; Zhao, Guangyu; Cheng, Guofeng; Tian, Yang; Gong, Ruo...
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 29:Issue 16(2019)
Page Start:
2415
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search